Abbott Laboratories (NYSE:ABT) Stock Price Target Raised at Robert W. Baird

Abbott Laboratories (NYSE:ABT) Stock Price Target Raised at Robert W. Baird

Robert W. Baird lifted their price objective on shares of Abbott Laboratories from $121.00 to $123.00 and gave the stock an "outperform" rating in a research report on Thursday.

JPMorgan Chase & Co. Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target reduced by investment analysts at JPMorgan Chase & Co. from $120.00 to $118.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the healthcare product maker’s stock. JPMorgan Chase & Co.’s target price points to a […]